Institutional Ownership
Revolution Medicines Inc
CUSIP 76155X100COMRVMDQ1 2026
Latest EPS (Diluted)
$-2.29
Q1 2026 · Mar 31, 2026
Latest Revenue
—
Reported quarter
Latest Net Income
-$453.82M
Reported quarter
Quarters on Record
12
From SEC XBRL filings
Quarterly Earnings
EPS, revenue & net income · SEC XBRL (10-Q / 10-K)
| Period | Quarter | EPS (Basic) | EPS (Diluted) | Revenue | Net Income | Form |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Q1 2026 | $-2.29 | $-2.29 | — | -$453.82M | 10-Q |
| Sep 30, 2025 | Q3 2025 | $-1.61 | $-1.61 | — | -$305.21M | 10-Q |
| Jun 30, 2025 | Q2 2025 | $-1.31 | $-1.31 | — | -$247.79M | 10-Q |
| Mar 31, 2025 | Q1 2025 | $-1.13 | $-1.13 | — | -$213.42M | 10-Q |
| Sep 30, 2024 | Q3 2024 | $-0.94 | $-0.94 | $0 | -$156.29M | 10-Q |
| Jun 30, 2024 | Q2 2024 | $-0.81 | $-0.81 | $0 | -$133.23M | 10-Q |
| Mar 31, 2024 | Q1 2024 | $-0.70 | $-0.70 | $0 | -$116.00M | 10-Q |
| Sep 30, 2023 | Q3 2023 | $-0.99 | $-0.99 | $0 | -$108.43M | 10-Q |
| Jun 30, 2023 | Q2 2023 | $-0.92 | $-0.92 | $3.82M | -$98.30M | 10-Q |
| Mar 31, 2023 | Q1 2023 | $-0.72 | $-0.72 | $7.01M | -$68.10M | 10-Q |
| Sep 30, 2022 | Q3 2022 | $-0.87 | $-0.87 | $3.36M | -$73.33M | 10-Q |
| Jun 30, 2022 | Q2 2022 | $-0.82 | $-0.82 | $9.12M | -$61.22M | 10-Q |